Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

NCT03907475 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

115

Enrollment

NIH

Sponsor class

Conditions

Locally Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
DRUG: Capecitabine
DRUG: Carboplatin
PROCEDURE: Computed Tomography
BIOLOGICAL: Durvalumab
PROCEDURE: Echocardiography Test
DRUG: Gemcitabine Hydrochloride
DRUG: Nab-paclitaxel
DRUG: Paclitaxel
DRUG: Pegylated Liposomal Doxorubicin Hydrochloride

Sponsor

National Cancer Institute (NCI)